Anti-KIR blocking antibodies has led to important therapeutic implications in NK cell immunotherapy. 1-7F9 is a human monoclonal antibody that cross reacts with KIR2DL-1, -2, -3 and prevents their ...

“We connect NK cells with tumor cells so they can destroy ... Innate Pharma’s therapies mark the dawn of a new generation of immunotherapy agents. “For the last 10 years, I think ...

Prof. MENG Guangxun's team from the Shanghai Institute of Immunity and Infection of the Chinese Academy of Sciences, and collaborators, have revealed a novel mechanism whereby a short form of IL-18, ...

When the researchers introduced NK cells into the cell cultures ... that AHA-1031 could have potential as a new type of cancer immunotherapy. If these findings are confirmed in future studies ...

Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

NK cells are emerging as a potentially safer ... The company is also hopeful that its approach could extend the use of cell-based immunotherapy for cancer to solid tumours, something that has ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.